HMGB1 and Sepsis: Activated PTEN inhibits PI3K/PDK1/Akt signaling, which further suppresses β-catenin activity to modulate regulatory T cells, suggesting that HMGB1/PTEN/β-catenin signaling in the induction of regulatory T cells represents a novel therapeutic strategy in the treatment of sepsis-induced lung injury [66].